Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Change in Acquisitions & Divestments (2016 - 2022)

Historic Change in Acquisitions & Divestments for Usana Health Sciences (USNA) over the last 8 years, with Q3 2022 value amounting to $4.5 million.

  • Usana Health Sciences' Change in Acquisitions & Divestments changed N/A to $4.5 million in Q3 2022 from the same period last year, while for Sep 2023 it was $4.5 million, marking a year-over-year increase of 6774.67%. This contributed to the annual value of $1.1 million for FY2024, which is 7019.87% down from last year.
  • Usana Health Sciences' Change in Acquisitions & Divestments amounted to $4.5 million in Q3 2022.
  • In the past 5 years, Usana Health Sciences' Change in Acquisitions & Divestments registered a high of $36.7 million during Q1 2019, and its lowest value of -$1.8 million during Q1 2022.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $2.4 million (2019), whereas its average is $7.6 million.
  • As far as peak fluctuations go, Usana Health Sciences' Change in Acquisitions & Divestments soared by 4870000.0% in 2018, and later crashed by 9976.83% in 2020.
  • Quarter analysis of 5 years shows Usana Health Sciences' Change in Acquisitions & Divestments stood at $18.1 million in 2018, then tumbled by 83.39% to $3.0 million in 2019, then crashed by 38.31% to $1.8 million in 2020, then plummeted by 97.24% to $51000.0 in 2021, then soared by 8731.37% to $4.5 million in 2022.
  • Its Change in Acquisitions & Divestments was $4.5 million in Q3 2022, compared to -$1.8 million in Q1 2022 and $51000.0 in Q2 2021.